CINQAIR

CINQAIR

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

Company

DUNS: 176697907

Effective Date

June 29, 2020

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Reslizumab(10 mg in 1 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NDC Product Code

59310-610

Application Number

BLA761033

Marketing Category

BLA (C73585)

Route of Administration

INTRAVENOUS

Effective Date

June 29, 2020

Ingredients

Code: 35A26E427HClass: ACTIBQuantity: 10 mg in 1 mL

SODIUM ACETATEInactive

Code: 4550K0SC9BClass: IACT

WATERInactive

Code: 059QF0KO0RClass: IACT

ACETIC ACIDInactive

Code: Q40Q9N063PClass: IACT

SUCROSEInactive

Code: C151H8M554Class: IACT